OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease
Philip J Smith, Mathurin Fuméry, Rupert W. Leong, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 9, pp. 1143-1156
Open Access | Times Cited: 7
Philip J Smith, Mathurin Fuméry, Rupert W. Leong, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 9, pp. 1143-1156
Open Access | Times Cited: 7
Showing 7 citing articles:
Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
Hesham M. El Mazar, El Sayed El Shayeb, Asmaa M. Ebrahim, et al.
Journal of the Egyptian Ophthalmological Society (2025) Vol. 118, Iss. 1, pp. 31-36
Open Access
Hesham M. El Mazar, El Sayed El Shayeb, Asmaa M. Ebrahim, et al.
Journal of the Egyptian Ophthalmological Society (2025) Vol. 118, Iss. 1, pp. 31-36
Open Access
Clinical use of biologics for Crohn’s disease in adults: lessons learned from real-world studies
Antonio Tursi, Giammarco Mocci, Angelo Del Gaudio, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 3, pp. 171-189
Closed Access | Times Cited: 3
Antonio Tursi, Giammarco Mocci, Angelo Del Gaudio, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 3, pp. 171-189
Closed Access | Times Cited: 3
Raising the bar in ulcerative colitis management
Fabrizio Fanizzi, Mariangela Allocca, Gionata Fiorino, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 1
Fabrizio Fanizzi, Mariangela Allocca, Gionata Fiorino, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 1
Switching from intravenous to subcutaneous infliximab and vedolizumab in patients with inflammatory bowel disease: impact on trough levels, day hospital visits, and medical expenses
Jenniina Harno-Tasihin, Laura Siregar, Mikko Paajanen, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 59, Iss. 3, pp. 280-287
Closed Access | Times Cited: 4
Jenniina Harno-Tasihin, Laura Siregar, Mikko Paajanen, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 59, Iss. 3, pp. 280-287
Closed Access | Times Cited: 4
Switching from Intravenous to Subcutaneous Biological Therapy for Inflammatory Bowel Disease Patients Remains a Challenge
Vered Richter, Daniel L. Cohen, Ofra Kriger-Sharabi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1357-1357
Open Access | Times Cited: 1
Vered Richter, Daniel L. Cohen, Ofra Kriger-Sharabi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1357-1357
Open Access | Times Cited: 1
Infliximab in Inflammatory Bowel Disease: Leveraging Physiologically Based Pharmacokinetic Modeling in the Clinical Context
Zvonimir Petrić, João Gonçalves, Paulo Paixão
Biomedicines (2024) Vol. 12, Iss. 9, pp. 1974-1974
Open Access
Zvonimir Petrić, João Gonçalves, Paulo Paixão
Biomedicines (2024) Vol. 12, Iss. 9, pp. 1974-1974
Open Access
Considerations in Paediatric and Adolescent Inflammatory Bowel Disease
S Vuijk, A Camman, Lissy de Ridder
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. Supplement_2, pp. ii31-ii45
Open Access
S Vuijk, A Camman, Lissy de Ridder
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. Supplement_2, pp. ii31-ii45
Open Access
